Generic Alyftrek 125mg/50mg/10mg tablets
NHS hospitals in England used £149,902,112 of indicative cost of Generic Alyftrek 125mg/50mg/10mg tablets in the 12 months to April 2026, about 0.6% of all hospital medicines spend. That is up 0.0% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Generic Alyftrek 125mg/50mg/10mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Generic Alyftrek 125mg/50mg/10mg tablets most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £15,916,680 |
| Guy's & St Thomas' Nhs Foundation Trust | £14,285,543 |
| Manchester University Nhs Ft | £12,784,436 |
| Univ Hpl B/Ham Nhs Foundation Trust | £11,055,488 |
| Leeds Teaching Hpls Nhs Trust | £11,019,240 |
| Univ Hpls Bristol Nhs Foundation Trust | £9,827,100 |
| Sheffield Teaching Hospitals Nhs Trust | £9,005,490 |
| University Hpls North Midlands Nhs Trust | £8,216,100 |
| King's College Hpl Nhs Foundation Trust | £7,829,460 |
| Frimley Health Nhs Foundation Trust | £6,121,800 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.